Abrol (ambroxol) tablets 30 mg. №20

Ambroxol tablets composition:

active ingredient: 1 tablet contains ambroxol hydrochloride 30 mg
excipients:  croscarmellose, microcrystalline cellulose, magnesium stearate.

Indications.

Secretolytic therapy for acute and chronic broncho-pulmonary diseases associated with impaired bronchial secretion and weakening of mucus movement.

Contraindications.

Abrol should not be used in patients with known hypersensitivity to ambroxol hydrochloride or any of the other ingredients of the drug.

Abrol 30 mg tablets is not intended for use in children under 6 years of age due to its potency. Children under the age of 6 years are recommended to use ambroxol in the appropriate dosage.

Application and dosage

Unless otherwise stated, the recommended dose of ambroxol tablets is:

• children aged 6 to 12 years: the dose is U ₂ 30-45 mg ambroxol hydrochloride per day)
• adults and children over 12 years of age: the dose is 1 tablet 3 times a day for the first 2-3 days (equivalent to 90 mg ambroxol hydrochloride per day). Continue treatment with 1 tablet 2 times a day (equivalent to 60 mg ambroxol hydrochloride per day).

If necessary, the therapeutic effect for adults and children over the age of 12 years can be enhanced by the use of 2 tablets 2 times a day (equivalent to 120 mg of ambroxol hydrochloride per day).

The ambroxol tablets should be swallowed whole with a sufficient amount of liquid (eg water, tea or fruit juice) after a meal.

In general, there are no restrictions on the duration of use, but long-term.